Literature DB >> 16610005

Hyperlactatemia in patients with non-acetaminophen-related acute liver failure.

Pilar Taurá1, Graciela Martinez-Palli, Julia Martinez-Ocon, Joan Beltran, Gerard Sanchez-Etayo, Jaume Balust, Teresa Anglada, Antoni Mas, Juan-Carlos Garcia-Valdecasas.   

Abstract

AIM: To characterize hyperlactatemia in patients with non-acetaminophen acute liver failure (ALF) in an attempt to clarify the mechanisms implicated and the role as a prognosis factor.
METHODS: In the setting of liver transplantation, 63 consecutive patients with non-acetaminophen acute liver failure were studied in relation to tissue oxygenation, hemodynamic and metabolic parameters. Before and after transplantation, the number of infected patients and outcome were registered.
RESULTS: Acute ALF showed higher levels of lactate than subacute ALF (5.4+/- 1 mmol/L versus 2.2+/- 0.6 mmol/L, P=0.01). Oxygenation parameters were within the normal range. Lactate levels showed good correlation with respiratory quotient (r=0.759, P< 0.005), mean glucose administration (r=0.664, P=0.01) and encephalopathy (r=0.698, P=0.02), but not with splanchnic arteriovenous difference in PCO2, pH and the presence of infection (P=0.1). Portal vein lactate was higher (P< 0.05) than arterial and mixed venous lactate, suggesting its production of hyperlactatemia in the intestine and spleen. The presence of infection was an independent predictor of survival.
CONCLUSION: Hyperlactatemia is not a prognosis factor due to byproduct of the overall acceleration in glycolysis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16610005      PMCID: PMC4087524          DOI: 10.3748/wjg.v12.i12.1949

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

1.  Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study.

Authors:  William Bernal; Nora Donaldson; Duncan Wyncoll; Julia Wendon
Journal:  Lancet       Date:  2002-02-16       Impact factor: 79.321

2.  Pulmonary lactate release in patients with acute lung injury is not attributable to lung tissue hypoxia.

Authors:  C Routsi; H Bardouniotou; V Delivoria-Ioannidou; D Kazi; C Roussos; S Zakynthinos
Journal:  Crit Care Med       Date:  1999-11       Impact factor: 7.598

3.  Splanchnic metabolism of fuel substrates in acute liver failure.

Authors:  J O Clemmesen; C E Høy; J Kondrup; P Ott
Journal:  J Hepatol       Date:  2000-12       Impact factor: 25.083

4.  The systemic inflammatory response syndrome in acute liver failure.

Authors:  N Rolando; J Wade; M Davalos; J Wendon; J Philpott-Howard; R Williams
Journal:  Hepatology       Date:  2000-10       Impact factor: 17.425

5.  The regional production of cytokines and lactate in sepsis-related multiple organ failure.

Authors:  E E Douzinas; P D Tsidemiadou; M T Pitaridis; I Andrianakis; A Bobota-Chloraki; K Katsouyanni; D Sfyras; K Malagari; C Roussos
Journal:  Am J Respir Crit Care Med       Date:  1997-01       Impact factor: 21.405

6.  Systemic and hepatic hemodynamic changes in acute liver injury.

Authors:  A J Makin; R D Hughes; R Williams
Journal:  Am J Physiol       Date:  1997-03

7.  Liver and intestinal lactate metabolism in patients with acute hepatic failure undergoing liver transplantation.

Authors:  N D Murphy; S K Kodakat; J A Wendon; C A Jooste; P Muiesan; M Rela; N D Heaton
Journal:  Crit Care Med       Date:  2001-11       Impact factor: 7.598

8.  Acute liver failure: redefining the syndromes.

Authors:  J G O'Grady; S W Schalm; R Williams
Journal:  Lancet       Date:  1993-07-31       Impact factor: 79.321

9.  Liver transplantation for acute liver failure: analysis of applicability.

Authors:  A Castells; J M Salmerón; M Navasa; A Rimola; J Saló; H Andreu; A Mas; J Rodés
Journal:  Gastroenterology       Date:  1993-08       Impact factor: 22.682

10.  Hepatic blood flow and splanchnic oxygen consumption in patients with liver failure. Effect of high-volume plasmapheresis.

Authors:  J O Clemmesen; A L Gerbes; V Gülberg; B A Hansen; F S Larsen; C Skak; N Tygstrup; P Ott
Journal:  Hepatology       Date:  1999-02       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.